Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

Published Date: 13 May 2024

DFS after three years was 87% after six years as opposed to 55% after three, but the toxicity was higher.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

2.

A garden can save your life

3.

Screening for prostate cancer: is it time to give up digital rectal examination?

4.

No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.

5.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot